The Effects of NLR,PLR,and FRA in Peripheral Blood on Normal Bone Mass and Bone Loss after Fractures
-
摘要:
目的 探讨系统性炎症指标中的中性粒细胞/淋巴细胞比率 、血小板/淋巴细胞比率、纤维蛋白/白蛋白比率,对骨折后骨质减少和骨质正常的影响。 方法 采用回顾性临床研究方法,所有数据均为昆明医科大学第一附属医院电子病例系统内公开信息和患者资料,期限为2023年1月至2023年9月,对病例库中骨折术后2 652例患者病历资料,根据患者骨密度检测结果进行分组,分别为骨质减少组141例、骨质正常组79例。根据采集的相关数据分别把每组的相关信息NLR、PLR、FAR、性别、年龄、甘油三酯、血糖、血压等相关信息采用SPSS25.0软件进行分析。 结果 NLR 、PLR、FAR在2组间差异无统计学意义(P > 0.05),BMI、年龄和性别差异有统计学意义(P < 0.05)。 结论 骨折后骨质减少的炎症反应可能与女性骨质疏松炎症因子不同。 Abstract:Objective To investigate the effects of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and fibrin/albumin ratio in systemic inflammatory markers on bone loss and normal bone function after fractures. Methods A retrospective study was conducted from January 2023 to September 2023 on the medical records of 2652 postoperative fracture patients publicly available in the electronic case system of the 1st Affiliated Hospital of Kunming Medical University. According to the results of bone density testing, patients were divided into two groups: 141 patients with the reduced bone mass and 79 patients with the normal bone mass. According to the collected data, the relevant information of each group, including NLR, PLR, FAR, gender, age, triglycerides, blood glucose, blood pressure, etc, was analyzed using SPSS 25.0 software.Results There was no significant statistical difference in NLR, PLR, and FAR between the two groups(P > 0.05). There were statistical differences in BMI , age and gender(P < 0.05). Conclusion The inflammatory response of bone loss after the fracture may be different from the inflammatory factors of female osteoporosis. -
Key words:
- Bone /
- Inflammatory factors /
- Peripheral blood /
- Fracture
-
表 1 各个临床指标与骨质减少的比较分析结果[M(P25,P75)/n(%)/($\bar x \pm s $)](1)
Table 1. Comparison of various clinical indicators with bone loss [M(P25,P75)/n(%)/($\bar x \pm s $)](1)
基本信息 骨质分类 Z/χ2/t P 正常(n=79) 减少(n=141) 年龄(岁) 40(34,47) 45(38,50) −2.267 0.023* 性别 6.182 0.013* 女 38(46.3) 44(53.7) 男 41(29.7) 97(70.3) 婚姻状况 0.974 0.324 已婚 67(34.7) 126(65.3) 未婚 12(44.4) 15(55.6) 高血压 1.077 0.299 无 73(37.1) 124(62.9) 有 6(26.1) 17(73.9) 糖尿病 2.600 0.107 无 79(37.1) 134(62.9) 有 0(0.0) 7(100.0) 吸烟 1.362 0.243 无 76(36.9) 130(63.1) 有 3(21.4) 11(78.6) 饮酒 0.319 0.572 无 78(36.4) 136(63.6) 有 1(16.7) 5(83.3) BMI(kg/m2) 25.10(23.31,27.99) 22.86(21.48,25.62) −4.144 0.000* 骨折类型 4.074 0.130 上肢骨折 24(37.5) 40(62.5) 下肢骨折 50(38.8) 79(61.2) 多发骨折 5(18.5) 22(81.5) 神经损伤 1.006 0.316 无 62(37.8) 102(62.2) 有 17(30.4) 39(69.6) 收缩压(mmHg) 124(115,129) 125(116,132) −1.079 0.280 舒张压(mmHg) 76(74,85) 78(75,84) −0.433 0.665 纤维蛋白原(g/L) 2.65(2.30,3.20) 2.70(2.30,3.30) −0.623 0.534 白蛋白(g/L) 40.65(38.83,42.58) 40.80(38.40,42.80) −0.145 0.885 FAR(纤/白) 0.0655 (0.0557 ,0.0787 )0.0665 (0.0554 ,0.0809 )−0.152 0.879 血糖(mmol/L) 4.80(4.50,5.20) 4.80(4.60,5.20) −0.586 0.558 血钙(mmol/L) 1.24(1.21,1.26) 1.24(1.22,1.26) −0.102 0.919 *P < 0.05。 表 1 各个临床指标与骨质减少的比较分析结果[M(P25,P75)/n(%)/($\bar x \pm s $)](2)
Table 1. Comparison of various clinical indicators with bone loss [M(P25,P75)/n(%)/($\bar x \pm s $)] (2)
基本信息 骨质分类 Z/χ2/t P 正常(n=79) 减少(n=141) 低密度脂蛋白(mmol/L) 3.12 ± 0.77 3.15 ± 0.76 −0.235 0.815 高密度脂蛋白(mmol/L) 1.05(0.82,1.20) 1.02(0.90,1.16) −0.105 0.916 甘油三酯(mmol/L) 1.42(1.08,2.29) 1.45(1.06,2.11) −0.278 0.781 淋巴细胞绝对值(×109/L) 1.91(1.49,2.24) 1.88(1.60,2.27) −0.431 0.667 血小板计数(×109/L) 237(204,274) 227(198,267) −0.904 0.366 中性粒细胞绝对值(×109/L) 3.10(2.50,3.70) 2.90(2.40,3.70) −0.002 0.998 单核细胞绝对值(×109/L) 0.43(0.36,0.54) 0.44(0.34,0.54) −0.271 0.786 NLR(中/淋) 1.62(1.28,2.08) 1.68(1.31,2.00) −0.458 0.647 PLR(血/淋) 125.14(99.18,148.69) 125.60(99.03,157.56) −0.058 0.954 表 2 影响骨质减少的多因素Logistic回归分析
Table 2. Multivariate logistic regression analysis of factors affecting bone loss
因素 B 标准误差 瓦尔德 P Exp(B) EXP(B) 的 95%CI 下限 上限 年龄 0.049 0.018 7.588 0.006* 1.051 1.014 1.088 性别 1.069 0.326 10.773 0.001* 2.912 1.538 5.512 BMI −0.218 0.049 20.101 0.000* 0.804 0.731 0.884 *P < 0.05。 -
[1] Marsell R,Einhorn T A. The biology of fracture healing[J]. Injury,2011,42(6):551-555. doi: 10.1016/j.injury.2011.03.031 [2] Claes L,Recknagel S,Ignatius A. Fracture healing under healthy and inflammatory conditions[J]. Nat Rev Rheumatol,2012,8(3):133-143. doi: 10.1038/nrrheum.2012.1 [3] Fullerton J N,Gilroy D W. Resolution of inflammation: A new therapeutic frontier[J]. Nat Rev Drug Discov,2016,15(8):551-567. doi: 10.1038/nrd.2016.39 [4] Lin T H,Tamaki Y,Pajarinen J,et al. Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target[J]. Acta Biomater,2014,10(1):1-10. doi: 10.1016/j.actbio.2013.09.034 [5] 张胜利,谢玲霞,杨欣建. 创伤后骨质疏松症的研究进展[J]. 临床医学,2006,26(6):88-89. [6] 周泽霖,尚奇,卓航,等. 男性原发骨质疏松症骨密度与新型炎症指标的相关性[J]. 中国骨质疏松杂志,2023,29(5):636-640. [7] Du Y N,Chen Y J,Zhang H Y,et al. Inverse association between systemic immune-inflammation index and bone mineral density in postmenopausal women[J]. Gynecol Endocrinol,2021,37(7):650-654. doi: 10.1080/09513590.2021.1885642 [8] 董晓芬,李香波,吴震宇,等. 绝经后2型糖尿病合并骨质疏松症患者外周血NLR、PLR、Cys-C水平与骨密度的相关性分析[J]. 临床和实验医学杂志,2022,21(2):174-177. doi: 10.3969/j.issn.1671-4695.2022.02.016 [9] 宋云霄,童巍,张海晨,等. 系统性炎症指标与老年骨质疏松症患者骨折发生的相关性[J]. 检验医学,2022,37(3):235-239. [10] Cun‐Yu Wang,Yu B. Osteoporosis and periodontal diseases - An update on their association and mechanistic links[J]. Periodontology 2000,2022,89(1):99-113. [11] Heuchert J ,Kozie S ,Spinek A E . Radiomorphometric indices of the mandible as indicators of decreased bone mineral density and osteoporosis - meta-analysis and systematic review[J]. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,2024,35(3): 401-412. [12] Karunanithi R,Ganesan S,Panicker T M,et al. Assessment of bone mineral density by DXA and the trabecular microarchitecture of the calcaneum by texture analysis in pre- and postmenopausal women in the evaluation of osteoporosis[J]. J Med Phys,2007,32(4):161-168. doi: 10.4103/0971-6203.37481 [13] Zupan J ,Komadina R ,Marc J . The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues[J]. Journal of Biomedical Science,2012,19(1): 1-10. [14] Kamel H M ,Amin E S ,El-Adawy A R . Endothelial and some cytokine inflammatory markers as risk factors of hypertension in postmenopausal women[J]. Life Science Journal,2014,11(3): 220-223. [15] 冯红红,高飞. 新型炎症因子与原发性骨质疏松症的研究进展[J]. 中国骨质疏松杂志,2022,28(1):152-156. [16] Zhao L J,Jiang H,Papasian C J,et al. Correlation of obesity and osteoporosis: Effect of fat mass on the determination of osteoporosis[J]. J Bone Miner Res,2008,23(1):17-29. doi: 10.1359/jbmr.070813 [17] Liu H W ,Lee K S. Effects of resistance training with elastic bands on bone mineral density,body composition,and osteosarcopenic obesity in elderly women: A meta-analysis[J]. Journal of Orthopaedics,2024,53(4):168-175. [18] Li Y. Association between obesity and bone mineral density in middle-aged adults[J]. J Orthop Surg Res,2022,17(1):268-274. doi: 10.1186/s13018-022-03161-x